Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Novo Nordisk's Canadian patent for weight loss drug Ozempic is set to expire in January 2026. Dr. Justin Ezekowitz discusses generic competitors that may come.